Loading…
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis
Ward, Melanie D, Jones, David E, Goldman, Myla D
Published in Expert opinion on drug safety (01.07.2014)
Published in Expert opinion on drug safety (01.07.2014)
Get more information
Journal Article
Loading…
The potential capacities of FTY720: Novel therapeutic functions, targets, and mechanisms against diseases
Liu, Juan, Zhang, Lu, Liu, Le, Wu, Tianfeng, Wang, Lin, Han, Qingzhen
Published in European journal of medicinal chemistry (05.06.2025)
Published in European journal of medicinal chemistry (05.06.2025)
Get full text
Journal Article
Loading…
An integrative mechanistic model of thymocyte dynamics
Kulesh, Victoria, Peskov, Kirill, Helmlinger, Gabriel, Bocharov, Gennady
Published in Frontiers in immunology (26.02.2024)
Published in Frontiers in immunology (26.02.2024)
Get full text
Journal Article
Loading…
A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models
Vidal-Martinez, Guadalupe, Chin, Brandon, Camarillo, Cynthia, Herrera, Gloria V., Yang, Barbara, Sarosiek, Irene, Perez, Ruth G.
Published in Journal of Parkinson's disease (01.01.2020)
Published in Journal of Parkinson's disease (01.01.2020)
Get full text
Journal Article
Loading…
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study
Frau, Jessica, Saccà, Francesco, Signori, Alessio, Baroncini, Damiano, Fenu, Giuseppe, Annovazzi, Pietro, Capobianco, Marco, Signoriello, Elisabetta, Laroni, Alice, La Gioia, Sara, Sartori, Arianna, Maniscalco, Giorgia Teresa, Bonavita, Simona, Clerico, Marinella, Russo, Cinzia Valeria, Gallo, Antonio, Lapucci, Caterina, Carotenuto, Antonio, Sormani, Maria Pia, Cocco, Eleonora
Published in Journal of neurology (01.10.2019)
Published in Journal of neurology (01.10.2019)
Get full text
Journal Article
Loading…
Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel‐group, phase I study in healthy subjects
Harada, Tomohiko, Wilbraham, Darren, La Borderie, Guillemette, Inoue, Shinsuke, Bush, Jim, Camm, A. John
Published in British journal of clinical pharmacology (01.05.2017)
Published in British journal of clinical pharmacology (01.05.2017)
Get full text
Journal Article
Loading…
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study
Abbadessa, Gianmarco, Schiavetti, Irene, Bollo, Luca, Cellerino, Maria, Miele, Giuseppina, Zanghì, Aurora, Cavalla, Paola, Signori, Alessio, Bulgari, Alessandro, Trotta, Maria, Scarano, Valentina, Fantozzi, Roberta, Landi, Doriana, Smolik, Krzysztof, Clerici, Valentina Torri, De Luca, Giovanna, Marinelli, Fabiana, Buttari, Fabio, Clerico, Marinella, Ferrazzano, Gina, Buscarinu, Maria Chiara, Pasquali, Livia, Tomasso, Ilaria, Vercellino, Marco, Maida, Elisabetta, Bile, Floriana, Lavorgna, Luigi, D’Amico, Emanuele, Inglese, Matilde, Sormani, Maria Pia, Iaffaldano, Pietro, Bonavita, Simona
Published in Journal of the neurological sciences (15.07.2025)
Published in Journal of the neurological sciences (15.07.2025)
Get full text
Journal Article
Loading…
Bioequivalence Study of 2 Capsule Formulations of Fingolimod 0.5 mg Assessing Both Parent Drug and Active Metabolite in New Zealand Healthy Subjects (Truncated Design)
Hung, Noelyn Anne, Costa, Fernando Guillermo, Hung, Cheung‐Tak, Rosenberg, Mónica Esther
Published in Clinical pharmacology in drug development (01.07.2020)
Published in Clinical pharmacology in drug development (01.07.2020)
Get full text
Journal Article
Loading…
Purmorphamine, a Smo-Shh/Gli Activator, Promotes Sonic Hedgehog-Mediated Neurogenesis and Restores Behavioural and Neurochemical Deficits in Experimental Model of Multiple Sclerosis
Prajapati, Aradhana, Mehan, Sidharth, Khan, Zuber, Chhabra, Swesha, Das Gupta, Ghanshyam
Published in Neurochemical research (01.06.2024)
Published in Neurochemical research (01.06.2024)
Get full text
Journal Article
Loading…
Effect of ceralifimod (ONO-4641) on lymphocytes and cardiac function: Randomized, double-blind, placebo-controlled trial with an open-label fingolimod arm
Krösser, Sonja, Wolna, Peter, Fischer, Tanya Z, Boschert, Ursula, Stoltz, Randall, Zhou, Meijian, Darpo, Borje
Published in Journal of clinical pharmacology (01.09.2015)
Published in Journal of clinical pharmacology (01.09.2015)
Get more information
Journal Article
Loading…
A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia
Enjeti, Anoop K, D'Crus, Angel, Melville, Kathleen, Verrills, Nicole M, Rowlings, Philip
Published in Anti-cancer drugs (01.07.2016)
Published in Anti-cancer drugs (01.07.2016)
Get more information
Journal Article
Loading…
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
König, Marton, Lorentzen, Åslaug Rudjord, Torgauten, Hilde Marie, Tran, The Trung, Schikora-Rustad, Stine, Vaage, Eline Benno, Mygland, Åse, Wergeland, Stig, Aarseth, Jan, Aaberge, Ingeborg Aase S, Torkildsen, Øivind, Holmøy, Trygve, Berge, Tone, Myhr, Kjell-Morten, Harbo, Hanne Flinstad, Andersen, Jan Terje, Munthe, Ludvig Andre, Søraas, Arne, Celius, Elisabeth Gulowsen, Vaage, John Torgils, Lund-Johansen, Fridtjof, Nygaard, Gro Owren
Published in Journal of neurology, neurosurgery and psychiatry (01.01.2023)
Published in Journal of neurology, neurosurgery and psychiatry (01.01.2023)
Get full text
Journal Article
Loading…
Changes in structural and functional connectivity during two years of fingolimod therapy for multiple sclerosis
Bhattacharyya, P.K., Lowe, M.J., Sakaie, K.E., Li, H., Lin, J., Fox, R.J.
Published in Magnetic resonance imaging (01.12.2020)
Published in Magnetic resonance imaging (01.12.2020)
Get full text
Journal Article
Loading…
Loading…
Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
Zhu, Chao, Zhou, Zhen, Roos, Izanne, Merlo, Daniel, Kalincik, Tomas, Ozakbas, Serkan, Skibina, Olga, Kuhle, Jens, Hodgkinson, Suzanne, Boz, Cavit, Alroughani, Raed, Lechner-Scott, Jeannette, Barnett, Michael, Izquierdo, Guillermo, Prat, Alexandre, Horakova, Dana, Kubala Havrdova, Eva, Macdonell, Richard, Patti, Francesco, Khoury, Samia Joseph, Slee, Mark, Karabudak, Rana, Onofrj, Marco, Van Pesch, Vincent, Prevost, Julie, Monif, Mastura, Jokubaitis, Vilija, van der Walt, Anneke, Butzkueven, Helmut
Published in Journal of neurology, neurosurgery and psychiatry (01.12.2022)
Published in Journal of neurology, neurosurgery and psychiatry (01.12.2022)
Get full text
Journal Article
Loading…
An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-β1 and fingolimod therapy
Acar, Nazire Pinar, Tuncer, Asli, Ozkazanc, Didem, Ozbay, Feyza Gul, Karaosmanoglu, Beren, Goksen, Sibel, Sayat, Guliz, Taskiran, Ekim Z., Esendagli, Gunes, Karabudak, Rana
Published in Journal of neuroimmunology (15.10.2020)
Published in Journal of neuroimmunology (15.10.2020)
Get full text
Journal Article
Loading…
Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy
Olberg, H. K., Eide, G. E., Cox, R. J., Jul‐Larsen, Å., Lartey, S. L., Vedeler, C. A., Myhr, K.‐M.
Published in European journal of neurology (01.03.2018)
Published in European journal of neurology (01.03.2018)
Get full text
Journal Article
Loading…
Fingolimod (Gilenya®) in multiple sclerosis: bradycardia, atrioventricular blocks, and mild effect on the QTc interval. Something to do with the L‐type calcium channel?
Pilote, Sylvie, Simard, Chantale, Drolet, Benoit
Published in Fundamental & clinical pharmacology (01.08.2017)
Published in Fundamental & clinical pharmacology (01.08.2017)
Get full text
Journal Article
Loading…
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy
Fujii, Chihiro, Kondo, Takayuki, Ochi, Hirofumi, Okada, Yoichiro, Hashi, Yuichiro, Adachi, Tetsuya, Shin-Ya, Masaharu, Matsumoto, Sadayuki, Takahashi, Ryosuke, Nakagawa, Masanori, Mizuno, Toshiki
Published in Scientific reports (18.10.2016)
Published in Scientific reports (18.10.2016)
Get full text
Journal Article
Loading…
Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables
Barone, Stefania, Palmieri, Camillo, Gallelli, Luca, Rania, Vincenzo, Pascarella, Angelo, Abatino, Antonio, Bruno, Pietro Antonio, Casarella, Alessandro, Pasquale, Marilisa, Manzo, Lucia, De Sarro, Giovambattista, Gambardella, Antonio, Valentino, Paola
Published in Neurotherapeutics (01.03.2024)
Published in Neurotherapeutics (01.03.2024)
Get full text
Journal Article